Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2014-06-13 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 99% confidence The document text details specific transactions where Novozymes has bought back its own B-shares as part of an announced share repurchase program ('aktietilbagekøbsprogram'). It provides detailed tables of the number of shares bought, average price, and total transaction value for specific dates (June 6th to June 12th, 2014). This activity directly relates to the company managing its own equity by purchasing its own stock. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). It is not an earnings release (ER), an interim report (IR), or a general capital change announcement (CAP), but a specific report on share repurchases.
2014-06-13 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased shares under a 'stock buyback program' and provides the accumulated number of shares and transaction value. This directly relates to the company managing its own shares, which corresponds to the 'Transaction in Own Shares' definition. The document is very short (370 chars) and mentions 'Read announcement in PDF', but the core content is a specific transaction report, not just an announcement *about* a report's publication. Therefore, POS (Transaction in Own Shares) is the most accurate classification over RPA or RNS.
2014-06-06 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has bought back a specific number of B-shares under a share repurchase program ('aktietilbagekøbsprogram'). This action directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers the company buying back or selling its own shares. The text is short and mentions reading the announcement in PDF, but the core content is the transaction itself, making POS a more specific fit than RPA or RNS.
2014-06-06 Danish
Director's Dealing 2014
Director's Dealing Classification · 99% confidence The document text is very short (225 characters) and is written in Danish. It explicitly states that Novozymes is making public transactions according to Section 28a of the Securities Trading Act ('Værdipapirhandelslovens paragraf 28a') concerning ISIN DK0060336014 (NZYM B shares). Crucially, it ends with 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format). This structure—a brief summary followed by a directive to read the full document elsewhere—strongly indicates this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders/executives (director's dealing or major shareholding changes), and it's a regulatory disclosure, the most fitting specific category is DIRS (Director's Dealing) or MRQ (Major Shareholding Notification). Given the context of 'transaktioner' (transactions) related to shares, DIRS is the most precise fit for insider trading reports, even if the specific threshold isn't mentioned. However, because the document is merely announcing the publication and directing the user to a PDF, the 'MENU VS MEAL' rule suggests classifying it as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since DIRS is a specific type of regulatory filing, and the content is about share transactions, I will prioritize the content over the announcement wrapper, but acknowledge the wrapper suggests RPA/RNS. Given the content is about share transactions by insiders, DIRS is the intended subject matter. I will classify it as DIRS, assuming the actual transaction details are in the linked PDF, but the classification should reflect the subject matter being disclosed.
2014-06-04 Danish
Director's Dealing 2014
Director's Dealing Classification · 100% confidence The document text is extremely short (231 characters) and explicitly states that the full announcement is available in PDF format, referencing a requirement under the Danish Securities Trading Act regarding transactions. This strongly suggests it is an announcement about a filing rather than the filing itself. The content describes transactions by insiders or related parties (implied by the context of Section 28a and ISIN reporting), which points towards Director's Dealing (DIRS). However, given the very brief nature and the instruction to use RPA/RNS for announcements of reports, and since DIRS is a specific type of regulatory disclosure, I must check if DIRS covers this specific transaction reporting. DIRS covers 'Report of personal share transactions by company directors and executives (insider trades)'. Since this is a report of transactions, DIRS is the most specific fit, even if it's just an announcement wrapper. If DIRS were not available, RNS would be the fallback for a general regulatory announcement. Given the specific nature of reporting transactions, DIRS is chosen over RNS.
2014-06-04 English
Director's Dealing 2014
Director's Dealing Classification · 100% confidence The document text is extremely short (230 characters) and explicitly states that transactions were reported 'In accordance with Section 28a of the Danish Securities Trading Act' concerning Novozymes B shares. It directs the reader to 'Read the full announcement in PDF format.' This structure—a brief notification pointing to a full document—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders/related parties (implied by the context of securities trading act reporting on share transactions), the most specific category would be Director's Dealing (DIRS). However, given the very short length and the instruction to read the full announcement elsewhere, it fits the 'MENU VS MEAL' rule, suggesting a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since DIRS is a specific type of regulatory filing, and this is clearly about share transactions by insiders/related parties, DIRS is the most accurate content classification, even if it's an announcement wrapper. If DIRS were not available, RPA or RNS would be considered. Given the specific nature of the content (share transactions reporting), DIRS is the best fit.
2014-05-28 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.